Municipalities Request 10% From Patients For Routine Vaccinations
This article was originally published in PharmAsia News
As cervical cancer, pneumococcus, and Hib vaccines are added to routine vaccinations in Japan, there are at least four municipalities in greater Tokyo that are requesting patients to pay 10% of the costs themselves,.
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.